Characteristics and Therapeutic Potential of Human Amnion-Derived Stem Cells
- PMID: 33478081
- PMCID: PMC7835733
- DOI: 10.3390/ijms22020970
Characteristics and Therapeutic Potential of Human Amnion-Derived Stem Cells
Abstract
Stem cells including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs) and adult stem cells (ASCs) are able to repair/replace damaged or degenerative tissues and improve functional recovery in experimental model and clinical trials. However, there are still many limitations and unresolved problems regarding stem cell therapy in terms of ethical barriers, immune rejection, tumorigenicity, and cell sources. By reviewing recent literatures and our related works, human amnion-derived stem cells (hADSCs) including human amniotic mesenchymal stem cells (hAMSCs) and human amniotic epithelial stem cells (hAESCs) have shown considerable advantages over other stem cells. In this review, we first described the biological characteristics and advantages of hADSCs, especially for their high pluripotency and immunomodulatory effects. Then, we summarized the therapeutic applications and recent progresses of hADSCs in treating various diseases for preclinical research and clinical trials. In addition, the possible mechanisms and the challenges of hADSCs applications have been also discussed. Finally, we highlighted the properties of hADSCs as a promising source of stem cells for cell therapy and regenerative medicine and pointed out the perspectives for the directions of hADSCs applications clinically.
Keywords: amniotic membrane; human amniotic epithelial stem cells; human amniotic mesenchymal stem cells; human amniotic stem cells; regenerative medicine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Amnion-derived cells as a reliable resource for next-generation regenerative medicine.Placenta. 2019 Sep 1;84:50-56. doi: 10.1016/j.placenta.2019.06.381. Epub 2019 Jun 25. Placenta. 2019. PMID: 31272680 Review.
-
Human amniotic membrane as an alternative source of stem cells for regenerative medicine.Differentiation. 2011 Mar;81(3):162-71. doi: 10.1016/j.diff.2011.01.005. Epub 2011 Feb 19. Differentiation. 2011. PMID: 21339039 Review.
-
The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy.BMB Rep. 2014 Mar;47(3):135-40. doi: 10.5483/bmbrep.2014.47.3.289. BMB Rep. 2014. PMID: 24499672 Free PMC article. Review.
-
Amniotic Mesenchymal Stromal Cells Exhibit Preferential Osteogenic and Chondrogenic Differentiation and Enhanced Matrix Production Compared With Adipose Mesenchymal Stromal Cells.Am J Sports Med. 2017 Sep;45(11):2637-2646. doi: 10.1177/0363546517706138. Epub 2017 May 25. Am J Sports Med. 2017. PMID: 28541092 Free PMC article.
-
Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy.Cell Transplant. 2008;17(8):955-68. doi: 10.3727/096368908786576507. Cell Transplant. 2008. PMID: 19069637
Cited by
-
Safety and biodistribution of exosomes derived from human induced pluripotent stem cells.Front Bioeng Biotechnol. 2022 Aug 26;10:949724. doi: 10.3389/fbioe.2022.949724. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36091443 Free PMC article.
-
Human amniotic membrane modulates Wnt/β-catenin and NF-κβ signaling pathways in articular chondrocytes in vitro.Osteoarthr Cartil Open. 2021 Sep 4;3(4):100211. doi: 10.1016/j.ocarto.2021.100211. eCollection 2021 Dec. Osteoarthr Cartil Open. 2021. PMID: 36474757 Free PMC article.
-
Recent advances in tendon tissue engineering strategy.Front Bioeng Biotechnol. 2023 Feb 20;11:1115312. doi: 10.3389/fbioe.2023.1115312. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 36890920 Free PMC article. Review.
-
Transplantation of Human Amniotic Mesenchymal Stem Cells Up-Regulates Angiogenic Factor Expression to Attenuate Diabetic Kidney Disease in Rats.Diabetes Metab Syndr Obes. 2023 Feb 7;16:331-343. doi: 10.2147/DMSO.S371752. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 36785675 Free PMC article.
-
Use of Amniotic Membrane and Its Derived Products for Bone Regeneration: A Systematic Review.Front Bioeng Biotechnol. 2021 May 11;9:661332. doi: 10.3389/fbioe.2021.661332. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34046400 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources